Using arts to improve quality of life for people with fibromyalgia

Museums as Health Spaces: Design and Evaluation of the Effectiveness of an Arts in Health Intervention to Improve the Quality of Life and Functional Capacity Regarding the Pain of People With Fibromyalgia. Mixed Methodology Study.

Not applicable Interventional Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina · NCT05993663

This study is testing whether a 12-session arts program can help improve the quality of life for people with fibromyalgia by using activities like mindfulness, dance, and creative thinking.

Quick facts

PhaseNot applicable
Study typeInterventional
Enrollment121 (estimated)
Ages18 Years and up
SexAll
SponsorFundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina Academic / other
Locations1 site (Figueres, Girona)
Trial IDNCT05993663 on ClinicalTrials.gov

What this trial studies

This intervention aims to assess the effectiveness of a 12-session program utilizing Arts in Health methodologies to enhance the quality of life for individuals with fibromyalgia. Participants will engage in mindfulness sessions, dance, and visual thinking strategies to better understand their condition and develop healthier habits. The study will compare outcomes with a control group using standardized quality of life assessments and will also gather qualitative feedback through focus groups to evaluate participants' experiences. The collaboration between health professionals and artists aims to create a comprehensive approach to managing fibromyalgia symptoms.

Who should consider this trial

Good fit: Ideal candidates for this study are adults over 18 years old who have been diagnosed with fibromyalgia or fibromyalgia with chronic fatigue syndrome.

Not a fit: Patients with serious concomitant rheumatological or psychiatric conditions that impede participation may not benefit from this study.

Why it matters

Potential benefit: If successful, this intervention could significantly improve the functional capacity and overall quality of life for patients suffering from fibromyalgia.

How similar studies have performed: While the use of arts in health is gaining traction, this specific approach to fibromyalgia is relatively novel and has not been extensively tested in previous studies.

Eligibility criteria

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Individuals diagnosed with fibromyalgia (M79.1) or diagnosed with fibromyalgia and chronic fatigue syndrome (T78.40 and M79.7)
2. Over 18 years old.
3. They agree to participate in the study and sign the informed consent.

Exclusion Criteria:

1. Serious concomitant rheumatological pathology, that is to say, that this involves a much more important functional disability than that caused by the fibromyalgia pathology itself.
2. Serious psychiatric pathology \[according to V Diagnostical and Statical Manual of Mental Disorders (DSM-V) criteria\] that could make it difficult to participate in the sessions and follow the study. Or that due to his psychiatric diagnosis, participation in a group was not advisable because of the negative impact it could cause.
3. Having previously participated in the group education project for people with fibromyalgia in Figueres Health Care Center.
4. Users who present a language barrier that makes good communication impossible.

Where this trial is running

Figueres, Girona

Study contacts

How to participate

  1. Review the eligibility criteria above with your treating physician.
  2. Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
  3. Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions FibromyalgiaArts in HealthMindfulnessVisual Thinking StrategiesRevised Fibromyalgia Impact Questionnaire
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.